Thalix
Thalix

1.73
This therapeutic option helps with cell growth regulation and tissue response modulation.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Thalidomide
Product Origin
Generic Brand
Product Manufacturer
Fresenius Kabi
Product Form
Capsule
Regulatory Classification
Rx
Primary Category
Oncology Support
Product Category
Immunomodulatory Agent
Pharmacological Class
Angiogenesis Inhibitor
Manufacturer Description
Formulated for multiple myeloma to target malignant cells and support immune modulation.
Mechanism of Action
Thalidomide possesses immunomodulatory, anti-inflammatory, and anti-angiogenic properties. It inhibits the production of tumor necrosis factor-alpha (TNF-alpha) and reduces the growth of new blood vessels that supply tumors.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
6–12 hours (half-life)
Contraindications
Pregnancy, Hypersensitivity to thalidomide, Females of childbearing potential not using contraception
Severe Adverse Events
Severe birth defects, Venous thromboembolism, Severe bradycardia — requires immediate medical attention
Common Side Effects
Somnolence, Fatigue, Constipation
Uncommon Side Effects
Peripheral neuropathy, Rash, Edema
Drug Interactions
Alcohol, Dexamethasone, Warfarin, Zidovudine
Pregnancy Safety Warnings
FDA Category X: Strictly contraindicated. Causes severe, life-threatening birth defects. Breastfeeding: Not recommended.
Age Restrictions
Not recommended for use in pediatric patients under 12 years of age.
Storage Guidelines
Store below 25°C.
Related Products
Thalomid, Revlimid
Information related to Thalix is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
How to buy Pain Management Drugs - Buy Diclofenac UK